Darwin - Procurement of Reagents and Consumables for Genomic Sequencing of COIVD Isolates

This order is to establish Genomic testing in NT on a scale commensurate with the testing associated with performing genome sequencing on COVID positive specimens. The cost is consistent with the pricing provided when purchasing the sequencing equipment. There are no indemnities or limits of liabilities associated with this procurement as the internal quality control processes verifies the testing is performing as expected within each and every run. When the internal quality control fails, results are not released and trouble-shooting processes are commenced. The company will replace any defective product at no additional cost to NT.